Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells

被引:55
作者
Stockmeyer, B
Beyer, T
Neuhuber, W
Repp, R
Kalden, JR
Valerius, T
Herrmann, M
机构
[1] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Anat 1, D-91054 Erlangen, Germany
关键词
D O I
10.4049/jimmunol.171.10.5124
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies in HER-2/neu-targeted immunotherapy demonstrated that polymorphonuclear neutrophils (PMN) mediated Ab-dependent cellular cytotoxicity against HER-2/neu-positive breast cancer cell lines. However, the mechanism of cell death remained unclear. We used several assays to analyze the induction of apoptosis in the breast cancer cell line SK-BR-3 via PMN-dependent Ab-dependent cellular cytotoxicity. In the presence of the HER-2/neu Ab 520C9 and PMN from healthy donors, apoptosis occurred as detected by annexin V binding and disappearance of euploid SK-BR-3 nuclei, which can be differentiated from PMN nuclei by their increased DNA contents. Apoptosis induction was observed with E:T cell ratios as low as 10:1. Laser scanning fluorescence microscopy of TUNEL tumor cells or staining for cleaved cytokeratin-18 further confirmed apoptosis of the SK-BR-3 breast cancer cells. Killing via 520C9 was dependent on the interaction with FcR on PMN, because 1) F(ab')(2) fragments of 520C9 mediated no cytotoxicity, 2) target cell death was influenced by a biallelic polymorphism of FcgammaRIIa on the effector cells, and 3) a bispecific Ab against HER-2/neu and the IgA receptor (FcalphaRI) expressed on effector cells significantly induced apoptosis. Thus, PMN induce Ab-dependent apoptosis against human breast cancer cells targeted with HER-2/neu-directed mAbs or FcR directed bispecific Abs.
引用
收藏
页码:5124 / 5129
页数:6
相关论文
共 45 条
[1]   Therapy with CD7 monoclonal antibody TH-69 is highly effective for xenografted human T-cell ALL [J].
Baum, W ;
Steininger, H ;
Bair, HJ ;
Becker, W ;
HansenHagge, TE ;
Kressel, M ;
Kremmer, E ;
Kalden, JR ;
Gramatzki, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (02) :327-338
[2]   Granules of the human neutrophilic polymorphonuclear leukocyte [J].
Borregaard, N ;
Cowland, JB .
BLOOD, 1997, 89 (10) :3503-3521
[3]   Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].
Cartron, G ;
Dacheux, L ;
Salles, G ;
Solal-Celigny, P ;
Bardos, P ;
Colombat, P ;
Watier, H .
BLOOD, 2002, 99 (03) :754-758
[4]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[5]  
COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
[6]   Complement mediated cell death is associated with DNA fragmentation [J].
Cragg, MS ;
Howatt, WJ ;
Bloodworth, L ;
Anderson, VA ;
Morgan, BP ;
Glennie, MJ .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (01) :48-58
[7]   The intriguing role of polymorphonuclear neutrophils in antitumor reactions [J].
Di Carlo, E ;
Forni, G ;
Lollini, P ;
Colombo, MP ;
Modesti, A ;
Musiani, P .
BLOOD, 2001, 97 (02) :339-345
[8]   HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor [J].
Elasser, D ;
Valerius, T ;
Repp, R ;
Weiner, GJ ;
Deo, Y ;
Kalden, JR ;
vandeWinkel, JGJ ;
Stevenson, GT ;
Glennie, MJ ;
Gramatzki, M .
BLOOD, 1996, 87 (09) :3803-3812
[9]  
GALE RP, 1975, J IMMUNOL, V114, P1047
[10]  
GLENNIE MJ, 1995, TUMOUR IMMUNOBIOLOGY, P225